Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …

Background: Early palliative care is increasingly used in solid organ malignancy but is less
established in patients with hematologic malignancy. Disease-related factors increase the …

Background: Patients with hematologic malignancies (HM) often receive aggressive care at
the end of life (EOL). Early palliative care (PC) has been shown to improve EOL care …

Abstract Purpose of Review The medical field has a critical role not only in prolonging life
but also in helping patients achieve a good death. Early studies assessing end-of-life quality …

BACKGROUND To the authors' knowledge, only limited data are available regarding the
quality of end‐of‐life care for patients with hematologic malignancies. In this retrospective …

Objectives To compare end‐of‐life (EOL) care for solid tumor and hematologic malignancy
(HM) patients. Methods We collected data on the last 100 consecutive deceased HM and …

Purpose Patients with blood cancers have been shown to receive suboptimal care at the
end of life (EOL) when assessed with standard oncology quality measures (eg, no …

Purpose: Hematologic cancers are associated with aggressive cancer-directed care near
death and underuse of hospice and palliative care services. We sought to explore …

Purpose: To measure intensity of end-of-life (EOL) care for Medicare cancer patients and
variations in care by age, gender, and race. Patients and Methods: This retrospective cohort …

Association between palliative care and end-of-Life care for... : Medicine Association between
palliative care and end-of-Life care for patients with hematological malignancies: A …